• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

APOEε4 genotype may increase risk of chronic traumatic encephalopathy following repetitive head impact

byGursharan SohiandMichael Pratte
July 1, 2022
in Chronic Disease, Emergency, Neurology
Reading Time: 3 mins read
Football head injury collage: an empty football helmet and a football resting on a strip of turf
Share on FacebookShare on TwitterShare on LinkedIn

1. A cross sectional study of postmortem brain specimens from individuals with a history of repetitive head impact found that individuals with the APOEε4 genotype were often burdened with a greater load of tau protein across several brain regions.

2. The encephalopathy in APOEε4 genotyped individuals was akin to that of someone who had played American football for approximately 7 years.

Evidence rating level: 2 (Good)

Study Rundown: Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease characterized by deposits of hyperphosphorylated tau protein found perivascularly, usually deep within the brain sulci. CTE is associated with a history of repetitive head trauma, often in the context of contact sports such as American football or boxing. The APOEε4 gene codes for a cholesterol transporter in the brain and is known to increase risk of other neurodegenerative diseases such as Alzheimer’s, while the APOEε2 genotype is protective. In this study, the relationship between CTE related to repetitive head injury (RHI) and APOEε4 genotype was investigated. A total of 364 donors with a history of RTI were included. Of these, 294 donors (80.8%) had neuropathologically-confirmed CTE. The overall allele frequency of the APOEε4 gene was 0.20 and was 0.06 for the APOEε2 gene. This study found that there were significant interactions between the APOEε4 gene and CTE stage as well as quantitative tau protein burden amongst donors over the age of 65. There was also a correlation between the APOEε4 genotype and dementia although the association was not statistically significant. Interestingly, none of these associations were significant in donors younger than 65 years of age. Finally, the study found that older (>65 years) individuals with the APOEε4 genotype had CTE levels comparable to having played football for approximately 7 years. In this study, Atherton et al demonstrate the burden of cognitive damage which may result from the APOEε4 genotype as a modifier of the risk of repetitive head injury. This information is clinically relevant because it further underscores the importance of head safety in sports by illustrating the repercussions later in life. Furthermore, the significant influence of older age provides further insight as to the pathogenesis of neurodegenerative disorders such as dementia and may pave the way for further studies of therapeutic options. A major limitation to this study was the cross-sectional study design and reliance on retrospective data from a melange of sources which could have introduced misclassification bias. However, the rigorous data analysis and correlation of neuropathological findings with clinical outcomes strengthens the conclusions made in this study.

Click here to read this study in JAMA Neurology

Relevant reading: Traumatic brain injury (TBI) in collision sports: possible mechanisms of transformation into chronic traumatic encephalopathy (CTE)

RELATED REPORTS

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

2 Minute Medicine Rewind Aug 24th, 2026 

In-Depth [cross sectional study]: A cross-sectional study was performed using donated brain specimens from the Veterans Affairs-Boston University Concussion Legacy Foundation Brain Bank. Eligible donors were Black or White men who had a history of RHI (i.e., defined as having played contact sports or done military service). DNA samples were extracted and sequenced to identify donors’ APOE genotype. Other relevant demographic, historical data and neuropathological data were gathered by a blinded team of researchers and pathologists. Of the 294 individuals with CTE, 14.3% had Stage I pathology, 21.4% had Stage II, 32.7% had Stage III and 31.6% had Stage IV CTE. Amongst donors older than 65 years, the odds of increased CTE stage by a single level amongst individuals with the APOEε4 genotype was 2.34 (95% confidence interval 1.30 to 4.20). The APOEε4 genotype was also associated with burden of tau protein as measured by an increase in the AT8+ pixel count by 1.39 units (95% confidence interval 0.83 to 1.94). Finally, the odds ratio between ​​APOEε4 genotype and dementia was 2.64 (95% confidence interval 1.06-6.61). In a sensitivity analysis excluding individuals who had been diagnosed with Alzheimer’s disease in life, the magnitude of association between RTI exposure and CTE stage was greater than the overall cohort. The association with dementia diagnosis was similar, and the association with tau protein load was decreased in comparison to the general analysis.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chronic traumatic encephalopathychronic traumatic encephalopathy (CTE)traumatic brain injury
Previous Post

The RAPTURE trial: Radiofrequency ablation effective and safe in lung cancer [Classics Series]

Next Post

Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers

RelatedReports

Brain health collage: an engraved brain in side view, a branching neuron, a plain brain-slice silhouette and a reflex hammer
Chronic Disease

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

August 27, 2026
Surgical outcomes collage: an operating lamp above a steel tray of scalpel, forceps and scissors beside a folded drape
Weekly Rewinds

2 Minute Medicine Rewind Aug 24th, 2026 

August 26, 2026
Obstetric scoring systems overestimate cases of severe sepsis
Infectious Disease

Propofol is associated with lower mortality in sepsis-associated encephalopathy

February 11, 2026
Brain disorders collage: a calm middle-aged man in a gray sweater beside a round brain inset, a penlight and a reflex hammer
Emergency

Prehospital postintubation hypotension following traumatic brain injury is associated with increased mortality

January 13, 2026
Next Post

Health system-based care associated with better treatment use and high rates of tobacco abstinence at 3 months post-discharge in hospitalized smokers

ABCD2 Score: Predicting Early Stroke Risk After Transient Ischemic Attack (TIA) [Classics Series]

Stereotactic body radiotherapy as a state of the art treatment option in inoperable non-small cell lung cancer [Classics Series]

Opioid prescribing collage: a calm man beside an amber pill bottle spilling white tablets onto a pill-counting tray

2 Minute Medicine Rewind July 4, 2022

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Non-inpatient care settings may offer alternatives to inpatient beds for select patients
  • Pirtobrutinib improves progression-free survival versus bendamustine plus rituximab in previously untreated CLL/SLL
  • Angiography-derived vessel fractional flow reserve (vFFR) was noninferior to pressure wire–based fractional flow reserve (FFR) for guiding revascularization in intermediate coronary stenoses
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.